Contact: Sitara Maruf
marufs@niaid.nih.gov
301-402-1663
NIH/National Institute of Allergy and Infectious Diseases

US and Indian Health Officials Renew the Indo-US Vaccine Action Program

Caption: On May 3, NIH and Indian officials signed a Joint Statement to renew the successful 20-year-old Indo-US Vaccine Action program for another five years. (Standing from left) Dr. S. Natesh, adviser scientist, Indian Department of Biotechnology; National Institutes of Health Director Dr. Elias A. Zerhouni; National Institute of Allergy and Infectious Diseases Director Dr. Anthony S. Fauci; Fogarty International Center Director Dr. Roger Glass; Secretary of the Indian Department of Biotechnology Dr. Maharaj K. Bhan; and Science and Technology Counselor from the Embassy of India, Dr. Kamal Kant Dwivedi.

Credit: National Institute of Allergy and Infectious Diseases

Usage Restrictions: None

Related news release: Health officials renew Indo-US Vaccine Action Program